JENNA GRIFFIN: Open Payments
NPI 1134523939 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 59 payments from 11 companies in 2025. Trend: 2023 $55 · 2024 $434 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $261 |
| Novo Nordisk Inc | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Alnylam Pharmaceuticals Inc. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $76 |
| BridgeBio Pharma, Inc. | 2 | $58 |
| PFIZER INC. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Abbott Laboratories | 1 | $20 |
Products named: LEQVIO, Wegovy, CAMZYOS, AMVUTTRA, JARDIANCE, Attruby, ELIQUIS, Kerendia.
Industry payments across TN — which companies pay providers there.
